Back to search
FDAFDA · Food and drugs·Recall number D-0661-2021

Topotecan Injection 4 mg/4mL (1 mg/mL), Single-Dose vial, Teva Pharmaceuticals USA, Inc. North Whales, PA 19454, Carton NDC# 0703-4714-01, Vial NDC# 0703-4714-71

Published July 14, 2021 · Recall initiated: June 18, 2021

Summary

FDA records drug Class I recall D-0661-2021, published July 14, 2021 and initiated June 18, 2021. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 10,425 vials; Lot: Lot # 31328962B, exp. date 04/2022. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Complaint received of a glass particle observed inside the vial. The vial was returned to Teva for further analysis where two other particulates were found and identified as one (1) grey silicone particle and one (1) translucent, colorless cotton fiber.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA
Distributor
Distributed Nationwide in the USA
Lot
Lot # 31328962B, exp. date 04/2022
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Topotecan Injection 4 mg/4mL (1 mg/mL), Single-Dose vial, Teva Pharmaceuticals USA, Inc. North Whales, PA 19454, Carton NDC# 0703-4714-01, Vial NDC# 0703-4714-71 recalled?

Yes. FDA published recall D-0661-2021 on July 14, 2021. Reported hazard: Presence of Particulate Matter: Complaint received of a glass particle observed inside the vial. The vial was returned to Teva for further analysis where two other particulates were found and identified as one (1) grey silicone particle and one (1) translucent, colorless cotton fiber.

What should I do if I have this product?

Voluntary: Firm initiated · Letter